361 related articles for article (PubMed ID: 28059043)
1. Natural Products as Anticancerous Therapeutic Molecules with Special Reference to Enzymatic Targets Topoisomerase, COX, LOX and Aromatase.
Singh S; Awasthi M; Pandey VP; Dwivedi UN
Curr Protein Pept Sci; 2018; 19(3):238-274. PubMed ID: 28059043
[TBL] [Abstract][Full Text] [Related]
2. Editorial: Natural Product Inhibitors of Enzymatic Targets in Anticancer Drug Discovery - Part I.
Scotti L; Scotti MT
Curr Protein Pept Sci; 2018; 19(3):236-237. PubMed ID: 29320979
[No Abstract] [Full Text] [Related]
3. Natural Products as Anti-Cancerous Therapeutic Molecules Targeted towards Topoisomerases.
Singh S; Pandey VP; Yadav K; Yadav A; Dwivedi UN
Curr Protein Pept Sci; 2020; 21(11):1103-1142. PubMed ID: 32951576
[TBL] [Abstract][Full Text] [Related]
4. Plant derived anti-cancerous secondary metabolites as multipronged inhibitor of COX, Topo, and aromatase: molecular modeling and dynamics simulation analyses.
Singh S; Awasthi M; Pandey VP; Dwivedi UN
J Biomol Struct Dyn; 2017 Nov; 35(14):3082-3097. PubMed ID: 27667581
[TBL] [Abstract][Full Text] [Related]
5. Natural products: promising resources for cancer drug discovery.
Mondal S; Bandyopadhyay S; Ghosh MK; Mukhopadhyay S; Roy S; Mandal C
Anticancer Agents Med Chem; 2012 Jan; 12(1):49-75. PubMed ID: 21707502
[TBL] [Abstract][Full Text] [Related]
6. Natural Product Inhibitors of Topoisomerases: Review and Docking Study.
Scotti L; Bezerra Mendonca FJ; Ribeiro FF; Tavares JF; da Silva MS; Barbosa Filho JM; Scotti MT
Curr Protein Pept Sci; 2018; 19(3):275-291. PubMed ID: 28079013
[TBL] [Abstract][Full Text] [Related]
7. Natural polyphenols properties: chemopreventive and chemosensitizing activities.
Delmas D; Xiao J
Anticancer Agents Med Chem; 2012 Oct; 12(8):835. PubMed ID: 22583400
[No Abstract] [Full Text] [Related]
8. Targeting arachidonic acid pathway by natural products for cancer prevention and therapy.
Yarla NS; Bishayee A; Sethi G; Reddanna P; Kalle AM; Dhananjaya BL; Dowluru KS; Chintala R; Duddukuri GR
Semin Cancer Biol; 2016 Oct; 40-41():48-81. PubMed ID: 26853158
[TBL] [Abstract][Full Text] [Related]
9. Multitargeted Molecular Docking Study of Natural-Derived Alkaloids on Breast Cancer Pathway Components.
Singla R; Jaitak V
Curr Comput Aided Drug Des; 2017 Nov; 13(4):294-302. PubMed ID: 28382865
[TBL] [Abstract][Full Text] [Related]
10. Bioactive natural products in cancer prevention and therapy: Progress and promise.
Bishayee A; Sethi G
Semin Cancer Biol; 2016 Oct; 40-41():1-3. PubMed ID: 27565447
[TBL] [Abstract][Full Text] [Related]
11. Network pharmacology-based virtual screening of natural products from Clerodendrum species for identification of novel anti-cancer therapeutics.
Gogoi B; Gogoi D; Silla Y; Kakoti BB; Bhau BS
Mol Biosyst; 2017 Jan; 13(2):406-416. PubMed ID: 28070575
[TBL] [Abstract][Full Text] [Related]
12. Targeting COX-2 expression by natural compounds: a promising alternative strategy to synthetic COX-2 inhibitors for cancer chemoprevention and therapy.
Cerella C; Sobolewski C; Dicato M; Diederich M
Biochem Pharmacol; 2010 Dec; 80(12):1801-15. PubMed ID: 20615394
[TBL] [Abstract][Full Text] [Related]
13. Molecular docking, QSAR and ADMET based mining of natural compounds against prime targets of HIV.
Vora J; Patel S; Sinha S; Sharma S; Srivastava A; Chhabria M; Shrivastava N
J Biomol Struct Dyn; 2019 Jan; 37(1):131-146. PubMed ID: 29268664
[TBL] [Abstract][Full Text] [Related]
14. Lipoxygenase directed anti-inflammatory and anti-cancerous secondary metabolites: ADMET-based screening, molecular docking and dynamics simulation.
Singh S; Awasthi M; Pandey VP; Dwivedi UN
J Biomol Struct Dyn; 2017 Feb; 35(3):657-668. PubMed ID: 26942689
[TBL] [Abstract][Full Text] [Related]
15. Current Perspectives in the Application of Medicinal Plants Against Cancer: Novel Therapeutic Agents.
Gezici S; Şekeroğlu N
Anticancer Agents Med Chem; 2019; 19(1):101-111. PubMed ID: 30582485
[TBL] [Abstract][Full Text] [Related]
16. DNA topoisomerase-directed anticancerous alkaloids: ADMET-based screening, molecular docking, and dynamics simulation.
Singh S; Das T; Awasthi M; Pandey VP; Pandey B; Dwivedi UN
Biotechnol Appl Biochem; 2016; 63(1):125-37. PubMed ID: 25594242
[TBL] [Abstract][Full Text] [Related]
17. Editorial; Natural Product Inhibitors of Enzymatic Targets in Anticancer Drug Discovery - Part II.
Scotti L; Scotti MT
Curr Protein Pept Sci; 2018 Feb; 19(4):342. PubMed ID: 29493446
[No Abstract] [Full Text] [Related]
18. Anticancer Natural Coumarins as Lead Compounds for the Discovery of New Drugs.
Pinto DCGA; Silva AMS
Curr Top Med Chem; 2017; 17(29):3190-3198. PubMed ID: 29243581
[TBL] [Abstract][Full Text] [Related]
19. Cancer prevention with promising natural products: mechanisms of action and molecular targets.
Pratheeshkumar P; Sreekala C; Zhang Z; Budhraja A; Ding S; Son YO; Wang X; Hitron A; Hyun-Jung K; Wang L; Lee JC; Shi X
Anticancer Agents Med Chem; 2012 Dec; 12(10):1159-84. PubMed ID: 22583402
[TBL] [Abstract][Full Text] [Related]
20. Prospective Plant Based Anticancer Lead Molecules.
Kaur P; Sharma V
Curr Top Med Chem; 2018; 18(30):2567-2583. PubMed ID: 30582476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
